Treatment-free Remission Accomplished With Dasatinib in Patients With CML
Clinical trial NCT02268370 · UNKNOWN
Trial details
- NCT number
- NCT02268370
- Sponsor
- University Health Network, Toronto
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2020-10-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.